Spikes, L. A., Bajwa, A. A., Burger, C. D., Desai, S. V., Eggert, M. S., El‐Kersh, K. A., Fisher, M. R., Johri, S., Joly, J. M., Mehta, J., Palevsky, H. I., Ramani, G. V., Restrepo‐Jaramillo, R., Sahay, S., Shah, T. G., Deng, C., Miceli, M., Smith, P., & Shapiro, S. M. (2022). bREEZE: Open‐label clinical study to evaluate the safety and tolerability of treprostinil inhalation powder as Tyvaso DPI™ in patients with pulmonary arterial hypertension. Pulmonary circulation, 12, n/a. http://access.bl.uk/ark:/81055/vdc_100158022382.0x00001c